Related Experiment Video
Updated: Jun 19, 2026

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Published on: March 16, 2018
Labile iron starvation in embryonic Kupffer cells aggravates MASH via mitochondrial failure and macrophage
Ke Wang1,2, Garam An1,3, Junho Park1,3
1Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, CA, USA.
Abstract:
Metabolically-dysfunction-associated steatohepatitis (MASH) is characterised by embryonic Kupffer cell (emKC) loss and proinflammatory macrophage infiltration. While iron dysregulation is implicated in MASH, the role of labile iron (Fe2 + ) in mediating emKC survival and function remains unknown. In human and mouse MASLD/MASH livers, emKCs exhibit repressed iron metabolism, reduced labile iron pools, and mitochondrial dysfunction. KC-specific ferroportin knockout mice recapitulate these defects, accelerating Western diet-induced steatosis and fibrosis. Conversely, ferritin depletion restores emKC labile iron levels, mitigates mitochondrial damage, and attenuates disease severity. Fe2+ deficiency blunts Trem2 expression, whereas restoring Fe2+ homeostasis elevates emKC Trem2 abundance in MASH liver. Weight loss reverses hepatic iron dysfunction and restores emKC homeostasis. Our findings establish labile iron deficiency as a key driver of emKC loss and functional switch in MASH, linking iron metabolism to mitochondrial fitness and inflammation. Targeting emKC iron homeostasis could offer novel therapeutic strategies for MASLD/MASH.
Insights
Labile iron deficiency drives loss of embryonic Kupffer cells in metabolic dysfunction-associated steatohepatitis (MASH). Restoring iron homeostasis in these cells may offer new MASH therapies.
Area of Science:
- Hepatology
- Immunology
- Metabolic Diseases
Background:
- Metabolic dysfunction-associated steatohepatitis (MASH) involves embryonic Kupffer cell (emKC) loss and inflammation.
- Iron dysregulation is linked to MASH, but the role of labile iron (Fe2+) in emKC function is unclear.
Purpose of the Study:
- Investigate the role of labile iron (Fe2+) in emKC survival and function in MASH.
- Determine if targeting emKC iron homeostasis can be a therapeutic strategy for MASH.
Main Methods:
- Analysis of human and mouse MASH livers for emKC iron metabolism and mitochondrial function.
- Utilized KC-specific ferroportin knockout mice and ferritin depletion models.
- Assessed Trem2 expression and effects of weight loss on hepatic iron.
Main Results:
- MASH livers show repressed emKC iron metabolism, reduced labile iron, and mitochondrial dysfunction.
- KC-specific ferroportin knockout accelerated MASH progression; ferritin depletion improved emKC function and reduced disease severity.
- Fe2+ deficiency decreased Trem2 expression, while iron restoration increased it; weight loss normalized emKC iron homeostasis.
Conclusions:
- Labile iron deficiency is a key factor in emKC loss and dysfunction in MASH.
- Iron metabolism is intrinsically linked to mitochondrial health and inflammation in MASH.
- Modulating emKC iron homeostasis presents a potential therapeutic avenue for MASH.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Microbes and Other Elemental Cycles
Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Hepatic Encephalopathy
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology